Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.15579
Abstract: Three biotherapies – etanercept, adalimumab and ustekinumab – are licensed in childhood psoriasis. The few data available on their efficacy and tolerance are mainly derived from industry trials. However, biological drug survival impacts long‐term performance… read more here.
Keywords: psoriasis; childhood psoriasis; drug survival; biological drug ... See more keywords
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10020200
Abstract: Introduction: Biologic drugs have dramatically improved severe eosinophilic asthma (SEA) outcomes. Our aim was to evaluate the long-term efficacy of biological therapy in SEA in a real-life setting and to identify the predictors for switching… read more here.
Keywords: biological drug; therapy; act; sea ... See more keywords
Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10092325
Abstract: Despite belonging to a relatively new class of pharmaceuticals, biological drugs have been used since the 1980s, when they brought about a breakthrough in the treatment of chronic diseases, especially cancer. They conquered a large… read more here.
Keywords: biological drug; 2015 2021; perspectives biological; trends perspectives ... See more keywords